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Keratitis-ichthyosis-deafness syndrome (KID) is a rare ectodermal dysplasia characterized by vascularizing keratitis,
profound sensorineural hearing loss (SNHL), and progressive erythrokeratoderma, a clinical triad that indicates a
failure in development and differentiation of multiple stratifying epithelia. Here, we provide compelling evidence
that KID is caused by heterozygous missense mutations in the connexin-26 gene, GJB2. In each of 10 patients with
KID, we identified a point mutation leading to substitution of conserved residues in the cytoplasmic amino terminus
or first extracellular domain of Cx26. One of these mutations was detected in six unrelated sporadic case subjects
and also segregated in one family with vertical transmission of KID. These results indicate the presence of a common,
recurrent mutation and establish its autosomal dominant nature. Cx26 and the closely related Cx30 showed
differential expression in epidermal, adnexal, and corneal epithelia but were not significantly altered in lesional
skin. However, mutant Cx26 was incapable of inducing intercellular coupling in vitro, which indicates its functional
impairment. Our data reveal striking genotype-phenotype correlations and demonstrate that dominant GJB2 mu-
tations can disturb the gap junction system of one or several ectodermal epithelia, thereby producing multiple
phenotypes: nonsyndromic SNHL, syndromic SNHL with palmoplantar keratoderma, and KID. Decreased host
defense and increased carcinogenic potential in KID illustrate that gap junction communication plays not only a
crucial role in epithelial homeostasis and differentiation but also in immune response and epidermal carcinogenesis.
Keratitis-ichthyosis-deafness syndrome (KID [MIM
148210]) is a rare heritable ectodermal dysplasia with
severe sensory impairment. Corneal epithelial defects,
scarring, and neovascularization cause progressive de-
cline of visual acuity and may eventually lead to blind-
ness. Congenital sensorineural hearing loss (SNHL) is
generally severe and bilateral, although unilateral or
moderate hearing impairment has been observed (Szym-
ko et al.2002). The skin is thickened and often has a
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coarse-grained appearance. Patients usually develop fol-
licular hyperkeratoses and well-circumscribed, erythem-
atous, hyperkeratotic plaques that are symmetrically dis-
tributed on the face and extremities. Palmoplantar ker-
atoderma (PPK) with a grainy surface is invariably present
(fig. 1). Other features include dystrophic hair and nail,
dental anomalies, and heat intolerance. Increased suscep-
tibility tomucocutaneous infections is commonand some-
times fatal in the neonatal period. Squamous cell carci-
noma of the skin and oral mucosa is a rare but serious
complication that can shorten life expectancy. To date,
∼70 cases, the majority of which are sporadic, have been
described in the world literature (Caceres-Rios et al.
1996). However, autosomal dominant and autosomal re-
cessive inheritance has been reported in a small number
of families (Legrand et al. 1982; Grob et al. 1987; Tup-
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Figure 1 Clinical features of KID. A, Sharply demarcated, figurate outlined, red-brown hyperkeratotic plaques on the central face and
outer rim of the ear (KID 05). B, Rarefied eyelashes and vascularizing keratitis (KID 05). C, Acanthosis of the skin with a heavy-grained leather
appearance (KID 08). D, Diffuse palmar keratoderma with grainy surface (KID 03). E, Chronic Candida albicans onychia and paronychia with
hypertrophy of distal digits, acanthosis, and hyperkeratosis of the skin (KID 09).
Figure 2 Mutation analysis of GJB2 in eight individuals affected with sporadic disease and one multiplex family with KID. A, Sequence
chromatograms of GJB2 from unaffected (left panel) and affected (right panel) family members, depicting the heterozygous transition 148GrA
at codon 50 encoding asparagine instead of aspartic acid (D50N) that is observed in seven unrelated families with KID. B, Genotyping by
automated pyrosequencing of biotinylated single-stranded DNA templates (Pyrosequencing) confirmed the presence of D50N in the affected
patients (top row,pyrogram; bottom row, outcome as bar graph; both were generated with Pyrosequencing software), whereas it was excluded
from unaffected parents and siblings and from 54 control subjects. Individuals from whom DNA was obtained are marked with an asterisk
(*). C and D, Sequence chromatograms of GJB2 from unaffected (left panel) and affected (middle panel) family members and the mutant allele
(right panel) subcloned in the pcDNA2.1 vector (Invitrogen), showing (C) the heterozygous GrC transversion in codon 12, replacing glycine
with arginine (G12R) in patient KID 08, and (D) the transition 50CrT, leading to substitution of serine 17 with phenylalanine (S17F), in one
allele of patient KID 09. E, Schematic of the Cx26 polypeptide that depicts structural motifs and location of mutations in KID. NTp amino-
terminus; M1–M4 p transmembrane domains 1–4, respectively; E1 and E2 p extracellular domains 1 and 2, respectively; CLp cytoplasmic
loop; and CT p carboxy-terminus.
purainen et al. 1988; Nazzaro et al. 1990; Kone-Paut et
al. 1998).
Recent advances in the molecular understanding of
hearing loss, vision, and skin disorders have emphasized
the pivotal role that gap junction cell-cell communication
plays in development and homeostasis of ectodermally
derived tissues. Gap junctions are tightly packed assem-
blies of intercellular channels that control and coordi-
nate a variety of cellular activities through the exchange
of small ions, metabolites, and signaling molecules. Each
connexin (Cx) channel consists of two connexon hemi-
channels that are built by hexameric oligomerization of
connexins (Cxs), a family of integral membrane proteins.
Gap junctions can be composed of similar or different Cx
proteins, forming homotypic or heterotypic channelswith
unique properties (Bevans et al. 1998). Dominant mu-
tations in the genes encoding Cx26, Cx30, and Cx31,
each of which is expressed in inner ear and skin, are
detrimental to the function of these tissues, causing
SNHL, skin disorders, or both (Kelsell et al. 2001; Ri-
chard 2001). Cutaneous disorders include those with Cx
mutations affecting GJB2 (GenBank accession number
XM_007169) in PPK/SNHL (MIM 148350) (Richard et
al. 1998b) and Vohwinkel syndrome (MIM 124500)
(Maestrini et al. 1999), GJB6 (GenBank accession num-
bers XM_007168 and NT_009917) in Clouston syn-
drome (MIM 129500) (Lamartine et al. 2000), andGJB3
(GenBank accession number AF_099730) and GJB4 in
erythrokeratodermia variabilis (EKV [MIM 133200])
(Richard et al. 1998a; Macari et al. 2000). On the basis
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Figure 3 Immunofluorescence (confocal microscopy) of normal (A, E, and I) and lesional (B–D, F–H, K, and L) skin in KID (KID 08)
with Cx26, Cx43, and Cx30 antibodies. Immunohistochemical analyses were performed on 5-mm–thick sections of snap-frozen skin biopsies
of normal control skin and lesional skin, as described elsewhere (Rouan et al. 2001). The primary monoclonal anti-Cx26 antibody (mouse
[Zymed Laboratories; catalog number 33-5800]), which does not cross-react with Cx30, was detected with fluorescein-conjugated anti-mouse
immunoglobin (green). The polyclonal anti-Cx43 and anti-Cx30 antibodies (rabbit [Zymed Laboratories]) were visualized with Texas
Red–conjugated anti-rabbit immunoglobin (red). Areas of focal colocalization of Cx26 with either Cx30 or Cx43 are visualized in yellow. A,
Normal epidermis, Cx26 (green). B–D, KID syndrome, Cx26 (green). Note the weak immunostaining of Cx26 in the granular cell layers (B,
arrows) but strong expression in epithelial cells of sweat ducts (C) and outer root sheath of hair follicles (oblique cut) (D). E,Normal epidermis,
Cx30 (red). F–H, KID syndrome, Cx30 (red) and Cx26 (green). Cx30 staining appears strictly compartmentalized with membranous and
cytoplasmic staining in basal keratinocytes and punctate membrane staining of the upper differentiated cell layers. Note the focal colocalization
of Cx26 and Cx30 in the granular epidermal layers (F, arrows), as well as in the sweat ducts (G) and hair follicles (H). I, Normal epidermis,
Cx43 (red). K and L, KID syndrome, Cx43 (red) and Cx26 (green). Comparable expression of Cx43 throughout the epidermis in normal (I)
and lesional skin (K) and colocalization of Cx26 with Cx43 in hair follicles (L). d p dermis; e p epidermis; sd p sweat duct; and hf p hair
follicle. Scale bars p 10 mm.
of the partially overlapping clinical features of these dis-
orders and those of KID, we consideredGJB2, GJB3, and
GJB6 as strong candidate genes.
We ascertained, as part of clinical and genetic studies
(by L.J.R., E.W.J., and G.R.) of KID, 8 unrelated subjects
affected with sporadic disease and 15 unaffected first-
degree relatives (fig. 2). Patients ranged in age from 2
to 47 years, and each demonstrated the cardinal features
of KID: progressive, vascularizing keratitis, SNHL con-
firmed by audiometry, PPK with reticulate surface, hy-
perkeratotic plaques on face or extremities, and acan-
thosis of other skin areas (fig. 1). Frequency of muco-
cutaneous infections, degree of erythema, and involve-
ment of hair and teeth were variable. At the time of
examination, none of the patients we studied had evi-
dence of squamous cell carcinoma. Two additional pa-
tients, an affected father and his son, were previously
reported by Tuppurainen et al. (1988) (fig. 2). All fam-
ilies were of European descent; five originated in the
United States, and one each originated in Australia, Fin-
land, Hungary, and the United Kingdom. All participants
gave informed consent, and DNA samples were collected
from patients and family members by use of either buccal
swabs or venous blood samples. We screened the coding
and flanking sequences of GJB2, GJB3, and GJB6 of
each patient by bidirectional direct DNA sequencing of
PCR amplicons obtained from genomic DNA, as de-
scribed elsewhere (Richard et al. 1998a, 1998b).
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Figure 4 Immunofluorescence of normal human corneal epithelium with Cx26 (A), Cx30 (B), and Cx43 (C) antibodies. All connexin
proteins showed, as expected, punctate staining at the cell membranes. A, Cx26 staining was relatively weak and was limited to the basal layer
of the epithelium. B, Comparatively strong Cx30 expression throughout the basal and lower wing layers, sparing the superficial wing and
squamous layers. C, Similar distribution of Cx43, with highest protein levels in the basal layer but staining extended throughout the wing
layers. Scale bar p 10 mm.
Without exception, we identified a heterozygous point
mutation in GJB2 in each of 10 patients with KID from
nine unrelated families. Six of eight sporadic cases carried
transition 148GrA resulting in substitution of aspartic
acid with asparagine in codon 50 (D50N). The same het-
erozygous mutation was detected in an affected father and
his son (fig. 2A, 2B, and 2E), confirming autosomal dom-
inant inheritance of KID on a molecular level. The pres-
ence of this mutation in seven unrelated probands of var-
ying ethnic origins but not in any of the unaffected parents
and siblings strongly suggests that D50N has arisen de
novo in each family and that it is a common mutation in
KID. This amino acid replacement occurs in the highly
conserved first extracellular loop of Cx26 (fig. 2E), which
is crucial for voltage gating (Rubin et al. 1992) and con-
nexon-connexon interactions (White et al. 1996). There-
fore, D50N may seriously compromise these functions.
Two sporadic cases of KID harbored differentGJB2mu-
tations, including transversion 34GrC, which leads to
replacement of glycine with arginine (G12R) and tran-
sition 50CrT,which substitutes serinewithphenylalanine
(S17F). Both nonconservativemutations (fig. 2C–E) affect
residues in the cytoplasmic amino-terminus that are con-
served among all b–type Cxs of different species, and both
are predicted to alter charge and structure of this domain.
These changes may interfere with conformation and flex-
ibility of the amino-terminus, as well as regulation of Cx
selectivity and gating polarity (Verselis et al. 1994; Falk
et al. 1997; Purnick et al. 2000). The functional impor-
tance of these residues is underscored by the fact that
missense mutations of corresponding or neighboring
residues cause EKV (Cx31 [G12R and G12D], Cx30.3
[G12D]), Clouston syndrome (Cx30 [G11R]) and X-
linked Charcot-Marie-Tooth disease (Cx32 [G12S])
(Richard 2001). No other sequence variants were iden-
tified in the patients’ coding sequences of GJB2, GJB3,
and GJB6. Mutations S17F, G12R, and D50N were not
present in at least 66 white control individuals nor in the
hundreds of individuals worldwide, who were screened
for recessive deafness mutations (see Connexin-Deafness
Homepage), excluding the possibility that these sequence
aberrations represent frequent polymorphisms.Therefore,
we conclude that these dominant GJB2 mutations cause
KID. The mutations are likely to disturb biogenesis of
Cx26 or to dominantly inhibit the function of gap junc-
tions, similar to mutations observed in other Cx disorders
(Martin et al. 1999; VanSlyke et al. 2000; Rouan et al.
2001).
Gap junctions formed by Cx26 are found in many
epithelial organs, including cochlea, palmoplantar epi-
dermis, hair follicles, and sweat glands and ducts. To
assess the effect that KID mutations have on the cuta-
neous Cx network, we studied Cx expression in lesional
skin from the back of proband KID 08, who is hetero-
zygous for G12R (fig. 3). Cx26 (green) was predomi-
nantly expressed in a punctate pattern at cell membranes
of eccrine sweat ducts and the outer root sheet of hair
follicles, similar to control skin. These observations dem-
onstrate that G12R does not interfere with the synthesis
and intracellular distribution of Cx26 in vivo. In these
adnexal structures, Cx26 colocalized (yellow) exten-
sively with Cx30 (red), indicating that wild-type and/or
mutant Cx26 may interact with Cx30 at junctional
plaques. In contrast to the absence of Cx26 staining in
normal truncal epidermis, we observed weak, focal, ec-
topic staining of Cx26 in the granular layers of lesional
epidermis, which also expressed Cx30 and Cx43. Since
distribution and intensity of Cx43 and Cx30 were not
significantly altered, we hypothesize that expression of
mutant Cx26 in KID may be detrimental to the function
of gap junctions by changing the normal level of Cx
signaling in skin. In normal human cornea (fig. 4A–C),
Cx43 and Cx30 were abundant, with widespread and
overlapping yet distinct distribution patterns that dif-
fered from the distribution reported for Cx50 (Matic et
al. 1997). In contrast, immunostaining revealed weak
expression of Cx26, limited to basal epithelial cells. This
distribution parallels that in rabbit cornea, in which
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Figure 5 Immunolocalization of wild-type Cx26 (A) and Cx26
S17F (B). HeLa cells expressing a tTA vector were stably transfected
with Cx26-MYC-cDNA/pCEP-TetP vectors, grown in selective me-
dium to 180% confluency, fixed, and stained with a monoclonal Cx26
antibody. A, WtCx26. B, Cx26 S17F. Arrows indicate plasma mem-
brane staining at cell-cell contacts. Scale bar p 10 mm.
Table 1







Wt Cx26 18 3.94  .32
Cx26 S17F 25 0.00  .00a
a .P ! .000001
Cx26 was shown to be transiently upregulated during
wound regeneration (Ratkay-Traub et al. 2001). These
findings suggest that the progressive keratitis in KIDmay
result from perpetually induced expression of mutant
Cx26.
To test the ability of mutant Cx26 to form functional
gap junction channels, we stably expressed wild-type
and mutant (S17F) Cx26 in coupling-incompetent HeLa
cells (fig. 5A and 5B). Then we injected the cytoplasm
of individual cells expressing either wild-type Cx26 or
mutant Cx26 with carboxyfluorescein (Mw 376 Da), a
fluorescent tracer that can freely pass through gap junc-
tion channels, and we scored the number of surrounding
cells receiving dye through gap junction coupling as-
sessed by means of fluorescence microscopy. In cells ex-
pressing wild-type Cx26, we observed a dye spread to
neighboring cells, with an average dye coupling of 3.94
 0.32 cells (18 experiments). In contrast, cells express-
ing comparable amounts of Cx26 S17F were completely
uncoupled (0.0 0.00; 25 experiments), indicating that
S17F abolishes the function of mutant Cx26 in vitro
(table 1). Our results are consistent with the functional
impairment determined for other dominant GJB2 mu-
tations, which were also shown to dominantly inhibit
the function of wild-type Cx26 (Richard et al. 1998b;
Martin et al. 1999; Rouan et al. 2001). A possible mech-
anism could be the integration of mutant proteins into
homo- or heteromeric connexons, which might block
their interactions with connexons in apposing cells, pro-
duce structurally incomplete channels, or alter selective
properties of gap junction channels.
KID is the third distinct disorder attributable to dom-
inantly inherited GJB2 mutations and highlights the re-
markable relationship that exists between GJB2 geno-
type and phenotype. Specific amino acid substitutions
clustered within the extracellular domain E1 of Cx26
(fig. 2E) can affect only the nonsensory epithelium of
the cochlea (W44C and W44S), the inner ear and epi-
dermis (DE42, G59A, D66H, and R75W), or, in addi-
tion, the corneal epithelium, hair follicles, and nails
(D50N). Although the determinants of this extraordi-
nary phenotypic variability are not understood, char-
acter and location of mutations likely influence struc-
tural and functional parameters of the gap junction
channels containing mutant Cx26. In addition, faulty
Cx26 may, directly or indirectly, hinder the function of
one or more partners in the Cx network. For example,
certain GJB2 mutations causing PPK/SNHL exert a se-
lective, trans-dominant inhibitory effect on the function
of Cx43 in vitro (Rouan et al. 2001). We suspect that
the GJB2 mutations described here cause KID via a sim-
ilar mechanism. For example, a dominant interference
with Cx30—which is expressed in epidermis, skin ap-
pendages, and cornea—could lead to the involvement of
these tissues in KID. This hypothesis is supported by the
fact that dominant germline mutations in the Cx30 gene
(GJB6) cause the ectodermal dysplasia Clouston syn-
drome, which also shows adnexal involvement, and by
the focal colocalization of Cx26 and Cx30 observed in
lesional skin. Corneal involvement could also stem from
additional interactions with the abundantly expressed
Cx43 or Cx50 (Matic et al. 1997).
The development of squamous cell carcinoma reported
in several patients with KID highlights the importance of
intact intercellular communication for growth control of
epithelial cells. Epithelial neoplasias, including squamous
cell carcinoma, show a significant loss of Cx26 expression
and downregulation of intercellular communication (Ka-
mibayashi et al. 1995; Sawey et al. 1996). Transfection
of Cx26 into coupling-deficient HeLa cells restores their
ability to communicate and significantly decreases their
proliferative potential. That dominant negative Cx26mu-
tants can reverse such a tumor-suppressive effect supports
the concept that Cx26 has a specific growth-regulatory
function (Mesnil et al. 1995).
Our data also constitute the first report linking a dis-
order with immune dysfunction to mutations in a Cx
gene. Various immune-competent cells show a differ-
ential expression of Cx proteins that seems tightly reg-
ulated by TNF-a, IL-2b, and other cytokines (Hu et al.
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1997; Saez et al. 2000). There is mounting evidence that
gap junction–mediated intercellular signaling coordi-
nates and synchronizes cellular actions to produce a
timely and effective immune response (Hu and Cot-
greave 1997; Saez et al. 2000). The exact mechanisms
by which dominant GJB2 mutations in KID reduce host
defense and influence susceptibility to mucocutaneous
infections, particularly with Candida albicans (Caceres-
Rios et al. 1996), remain to be determined.
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